Genelux | Investor Presentation Deck

Slide schematic 7/7

callout 1/1 diagram 1/1 list 1/1 paragraph 1/1 source-note 1/1 table 1/1 title 1/1

Components 7

primary process bullet paragraph source-note kpi headline

Tools 1

list/bullet: Key Inclusion Criteria: High-grade serous, endometrioid, or clear-cell ovarian cancer; Platinum-resistant or -refractory disease; Received prior bevacizumab; Received min 3 prior lines of therapy; ECOG 0 or 1.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

clinical-trial-design 90%

Standard structure for reporting clinical trial protocols (Inclusion criteria, arms, endpoints)

Find anything

The slide outlines a randomized, open-label trial comparing Olvi-Vec + Platinum-doublet + Bevacizumab against a standard comparator arm.